pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 3
darovasertib
Metastatic Uveal Melanoma
$IDYAIDEAYA Biosciences, Inc.
0 catalysts
Preclinical
dasatinib monolauryl sulfate_
dasatinib monolauryl sulfate
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Handa Pharmaceuticals LLC
0 catalysts
pre_registration
datopotamab deruxtecan
Datroway (datopotamab deruxtecan)
Triple-Negative Breast Cancer (TNBC)
DNA topoisomerase 1Tumor-associated calcium signal transducer 2
← prev
page 44 of 62
next →
131
Pain89
Neurology1
Daiichi Sankyo Co Ltd
0 catalysts
Marketed
daunorubicin hydrochloride
Daunorubicin Hydrochloride (daunorubicin hydrochloride)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Hisun Pharmaceutical USA Inc
0 catalysts
Phase 2
daznelimgene lisbac
daznelimgene lisbac [INN]
Osteosarcoma
$OSTXOS Therapies Inc
0 catalysts
Phase 3
defactinib hydrochloride
Fallopian Tube Cancer
$VSTMVerastem, Inc.
0 catalysts
Phase 2
deflexifol
Metastatic Colorectal Cancer
FivePhusion Pty Ltd
0 catalysts
Marketed
degarelix acetate
Firmagon (degarelix acetate)
Metastatic Prostate Cancer
Ferring Pharmaceuticals Inc
0 catalysts
Phase 2
dencatistat
dencatistat [INN]
Cutaneous T-Cell Lymphoma
Step Pharma
0 catalysts
Phase 1
denikitug
Solid Tumor
$GILDGILEAD SCIENCES, INC.
0 catalysts
pre_registration
denileukin diftitox
Ontak (denileukin diftitox)
Mycosis Fungoides
Interleukin-2 receptorElongation factor 2
$CTORCITIUS ONCOLOGY, INC.
0 catalysts
Phase 2
detalimogene voraplasmid
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
$ENGNenGene Therapeutics Inc.
0 catalysts
Phase 2
devimistat
devimistat [INN]
Bile Duct Cancer (Cholangiocarcinoma)
Cornerstone Pharmaceuticals Inc
0 catalysts
Phase 3
dexamethasone sodium phosphate
SEMDEXA (dexamethasone sodium phosphate)
Ataxia-Telangiectasia (Louis-Bar Syndrome)
Glucocorticoid receptor
$QNCXQuince Therapeutics, Inc.
0 catalysts
Phase 2
dibotatug
Leukemia
Dren Bio Inc
0 catalysts
Phase 2
dilanubicel
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Deverra Therapeutics Inc
0 catalysts
Phase 2
dimesna
dimesna [INN]
Non-Small Cell Lung Cancer
$LTRNLantern Pharma Inc.
0 catalysts
Marketed
dinutuximab
Unituxin (dinutuximab)
Neuroblastoma
$UTHRUNITED THERAPEUTICS Corp
0 catalysts
Phase 2
dinutuximab beta
dinutuximab beta [INN]
Ewing Sarcoma
Recordati SpA
0 catalysts
Phase 2
disitamab vedotin
Metastatic Transitional (Urothelial) Tract Cancer
Receptor tyrosine-protein kinase erbB-2Tubulin
$PFEPFIZER INC
0 catalysts
Phase 2
disufenton sodium
Recurrent Malignant Glioma
Oblato Inc
0 catalysts
Phase 3
divarasib
Non-Small Cell Lung Cancer
Genentech Inc
0 catalysts
Phase 2
divesiran
divesiran [INN]
Polycythemia Vera
$SLNSilence Therapeutics plc
0 catalysts
Phase 1
docirbrutinib mesylate
Lymphoma
Carna Biosciences Inc
0 catalysts
Marketed
dordaviprone hydrochloride
Modeyso (dordaviprone hydrochloride)
Glioma
$JAZZJazz Pharmaceuticals plc
0 catalysts
Phase 2
dorocubicel
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Cordex Biologics Inc
0 catalysts
Preclinical
dovitinib lactate
Osteosarcoma
Oncoheroes Biosciences Inc
0 catalysts
Phase 2
dubodencel
dubodencel [INN]
Glioblastoma Multiforme (GBM)
Diakonos Oncology Corp
0 catalysts
Phase 3
dulpatatug
dulpatatug [INN]
Adenocarcinoma Of The Gastroesophageal Junction
Shanghai Henlius Biotech Inc
0 catalysts
Phase 2
durvalumab + IPH-5201
Non-Small Cell Lung Cancer
$AZNASTRAZENECA PLC
0 catalysts